Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/GLAND stock hub

NSE/GLAND has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/GLANDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

313.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/GLAND

In the news

Latest news · NSE/GLAND

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.1

P25 24.9P50 32.4P75 45.7

Trailing P/E37

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC10.5

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/GLAND market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

INR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	4,351
Employees Change	134%
Employees Change Percent	3.18
Enterprise value	INR 284.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE068V01023
Last refreshed	2026-05-10
Market cap	INR 313.8B
Price	INR 1,906
Price currency	INR
Rev Per Employee	14,049,112.85x
Sector	Healthcare
Sic	2834
Symbol	nse/GLAND
Website	https://www.glandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.7%
EV Earnings	33.61x
EV/EBIT	27.53x
EV/EBITDA	19.81x
EV/Sales	4.66x
Forward P/E	29.15x
P/B ratio	3.28x
P/E ratio	37.04x
P/S ratio	5.13x
PE Ratio3 Y	37.91x
PE Ratio5 Y	40.15x
PEG ratio	0.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.92%
EBITDA Margin	23.21%
Gross margin	58.86%
Gross Profit	INR 36B
Gross Profit Growth	13.44%
Gross Profit Growth Q	22.85%
Gross Profit Growth3 Y	23.63%
Gross Profit Growth5 Y	15.56%
Net Income	INR 8.5B
Net Income Growth	20.27%
Net Income Growth Q	27.74%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	-5%
Net Income Growth5 Y	-1.88%
Pretax Margin	20.4%
Profit Margin	13.86%
Profit Per Employee	INR 1.9M
Profitable Years	9
Roa5y	8.86
Roe5y	13.37
ROIC	10.55
Roic5y	20.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	37.06%
Cagr3y	11.62%
Cagr5y	-5.99%
EPS Growth	20.25
EPS Growth Q	27.78
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	-4.97
EPS Growth5 Y	-2.94
Revenue Growth	6.7x
Revenue Growth Q	22.49x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	15.74x
Revenue Growth5 Y	13.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 32B
Debt	INR 3B
Debt EBITDA	INR 0.21
Debt Equity	INR 0.03
Equity	INR 95.6B
Interest Coverage	39.63
Net Cash	INR 29B
Net Cash By Market Cap	INR 9.24
Net Cash Growth	11.36%
Net Debt EBITDA	INR -2.04
Net Debt Equity	INR -0.3
Tangible Book Value	INR 91.7B
Tangible Book Value Per Share	INR 557
WACC	6.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 18
Dividend Years	2
Dividend Yield	0.95%
Ex Div Date	2025-08-14
Last Dividend	INR 18
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	37.03%
200-day SMA	1,829.2
3Y total return	39.07%
50-day SMA	1,736.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-26.57%
All Time High	4,350
All Time High Change	-56.18%
All Time High Date	2021-08-12
All Time Low	861
All Time Low Change	121.37%
All Time Low Date	2023-05-22
ATR	57.22
Beta	0.38
Beta1y	0.61
Beta2y	0.46
Ch YTD	10.69
High	1,922.7
High52	2,131
High52 Date	2025-07-29
High52ch	-10.56%
Low	1,866.2
Low52	1,384.4
Low52 Date	2025-05-09
Low52ch	37.68%
Ma50ch	9.76%
Price vs 200-day SMA	4.2%
RSI	65.69
RSI Monthly	52.98
RSI Weekly	58.8
Sharpe ratio	1.2x
Sortino ratio	2.18
Total Return	0.93%
Tr YTD	10.69
Tr1m	11.05%
Tr1w	4.99%
Tr3m	2.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 10.3B
Operating Income Growth	14.25
Operating Income Growth Q	24.13
Operating Income Growth3 Y	-0.96
Operating Income Growth5 Y	-1.52
Operating margin	16.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	79,359,539%
Shares Insiders	0%
Shares Institutions	38.18%
Shares Out	164,756,423
Shares Qo Q	0.01%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	139,131.4x
Bv Per Share	580.5
Ch1m	11.05
Ch1w	4.99
Ch1y	35.77
Ch3m	2.97
Ch3y	36.38
Ch5y	-28
Ch6m	2.31
Change	1.89%
Change From Open	1.88
Close	1,870.6
Days Gap	0.02
Depreciation Amortization	3,847,275,000
Dollar Volume	520,063,536
Earnings Date	2026-05-15
EBIT	INR 10.3B
EBITDA	INR 14.2B
EPS	INR 51.42
F Score	2
Fiscal Year End	March
Founded	1,978
Graham Number	819.49148
Graham Upside	-57
Income Tax	INR 4B
Is Primary Listing	1
Last Earnings Date	2026-01-28
Last Report Date	2025-12-31
Lynch Fair Value	INR 257
Lynch Upside	-86.51
Ma150	1,783
Ma150ch	6.9%
Ma20	1,779.4
Ma20ch	7.12%
Next Earnings Date	2026-05-15
Open	1,870.9
Payment Date	2025-09-28
Position In Range	70.44
Price Date	2026-05-08
Price EBITDA	INR 22.11
Ptbv Ratio	3.42
Relative Volume	2.14x
Revenue	61,127,690,000x
Tax By Revenue	6.54x
Tax Rate	32.07%
Tr6m	2.31%
Volume	272,856

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/GLAND dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$18.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.9%

Next ex-dividend date: 2025-08-14

Performance

NSE/GLAND stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/GLAND?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.2%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/GLAND momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.7

Neutral momentum band

Price vs 200-day MA

+4.2%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/GLAND

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/GLAND stock rating?

nse/GLAND is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/GLAND analysis?

The full report lives at /stocks/nse/GLAND/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/GLAND?

The latest report frames nse/GLAND around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/GLAND page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.